-transparent.png){kind=logo}
DNQX, an antagonist of AMPA/kainate receptors, was injected into the ventral tegmental area (VTA) to test the hypothesis that AMPA/kainate receptors in this brain region might be involved in regulation of locomotor activity. Bilateral injection of 1 microgram DNQX into the VTA increased locomotor activity. In addition, unilateral injection of DNQX into this site produced contraversive turning, which was potentiated by coadministration of amphetamine (1 mg/kg, i.p.). These results suggest that a glutamatergic afferent to the VTA is tonically active in inhibiting locomotor activity. The locomotor stimulation produced by DNQX was not associated with a change in DOPAC/DA level in the nucleus accumbens or the striatum. However, the locomotor stimulation produced by DNQX was markedly attenuated following blockade of dopaminergic receptors by haloperidol (0.5 mg/kg, s.c.) or following dopamine depletion induced by reserpine plus alpha-methyl-para-tyrosine pretreatment. These results suggest that a basal activation of dopaminergic receptors is required for expression of the locomotor activity elicited by DNQX.
A Dalia, and
N J Uretsky, and
L J Wallace
February 1979,
Brain research,
A Dalia, and
N J Uretsky, and
L J Wallace
January 2000,
The Journal of pharmacology and experimental therapeutics,
A Dalia, and
N J Uretsky, and
L J Wallace
May 1979,
Neuropharmacology,
A Dalia, and
N J Uretsky, and
L J Wallace
September 2020,
Behavioural brain research,
A Dalia, and
N J Uretsky, and
L J Wallace
June 1980,
Brain research,
A Dalia, and
N J Uretsky, and
L J Wallace
May 1996,
Journal of psychiatry & neuroscience : JPN,
A Dalia, and
N J Uretsky, and
L J Wallace
January 2019,
Advanced biomedical research,
A Dalia, and
N J Uretsky, and
L J Wallace
January 2011,
PloS one,
A Dalia, and
N J Uretsky, and
L J Wallace
September 1981,
Brain research,
A Dalia, and
N J Uretsky, and
L J Wallace
August 2000,
Psychopharmacology,
